Appili Therapeutics Inc. (APLIF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -8.03 Million CAD | 73.87% |
| 2023 | -7.9 Million CAD | -65.11% |
| 2022 | -24.66 Million CAD | 12.53% |
| 2021 | -15.64 Million CAD | -274.13% |
| 2020 | -5.38 Million CAD | 39.09% |
| 2019 | -6.52 Million CAD | -90.53% |
| 2018 | -6.54 Million CAD | 0.24% |
| 2017 | -3.21 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.16 Million CAD | 41.89% |
| 2024 FY | - CAD | 65.93% |
| 2024 Q3 | -1.91 Million CAD | -64.69% |
| 2024 Q4 | -2.41 Million CAD | -25.95% |
| 2024 Q1 | -2 Million CAD | 9.07% |
| 2023 Q1 | -2 Million CAD | 8.13% |
| 2023 Q4 | -2.17 Million CAD | 7.87% |
| 2023 FY | - CAD | -65.11% |
| 2023 Q3 | -2.36 Million CAD | -103.32% |
| 2023 Q2 | -1.16 Million CAD | 41.89% |
| 2022 Q2 | -11.04 Million CAD | -50.87% |
| 2022 FY | - CAD | 12.53% |
| 2022 Q4 | -2.17 Million CAD | 27.8% |
| 2022 Q3 | -3.01 Million CAD | 72.67% |
| 2022 Q1 | -7.32 Million CAD | -48.03% |
| 2021 FY | - CAD | -274.13% |
| 2021 Q3 | -4.23 Million CAD | -71.79% |
| 2021 Q1 | -2.59 Million CAD | -106.88% |
| 2021 Q2 | -2.46 Million CAD | 5.07% |
| 2021 Q4 | -4.94 Million CAD | -16.79% |
| 2020 FY | - CAD | 39.09% |
| 2020 Q4 | -1.25 Million CAD | -9.95% |
| 2020 Q3 | -1.14 Million CAD | -3.0% |
| 2020 Q2 | -1.1 Million CAD | 41.11% |
| 2020 Q1 | -1.88 Million CAD | -52.12% |
| 2019 Q1 | -675.27 Thousand CAD | 64.03% |
| 2019 FY | - CAD | -90.53% |
| 2019 Q2 | -1.29 Million CAD | -91.64% |
| 2019 Q3 | -1.14 Million CAD | 11.5% |
| 2019 Q4 | -1.23 Million CAD | -8.01% |
| 2018 FY | - CAD | 0.24% |
| 2018 Q4 | -1.87 Million CAD | 17.1% |
| 2018 Q3 | -2.26 Million CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 88.687% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -35.548% |
| SQZ Biotechnologies Company | -64.14 Million USD | 87.471% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 53.733% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 108.546% |
| Mesoblast Limited | -62.38 Million USD | 87.119% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -423.195% |
| Genus plc | 73.7 Million USD | 110.904% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -21.553% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -126.573% |
| Marizyme, Inc. | -34.28 Million USD | 76.557% |
| ContraFect Corporation | -64.99 Million USD | 87.636% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 8.384% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -77.556% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -473.297% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -203.902% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -245.833% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -1451.316% |
| Accustem Sciences Inc. | -3.74 Million USD | -114.512% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 83.336% |
| EV Biologics, Inc. | -1.26 Million USD | -534.23% |
| Q BioMed Inc. | -617.62 Thousand USD | -1201.192% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 324.987% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1170.786% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -251.787% |
| Biomind Labs Inc. | -1.03 Million USD | -676.815% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 181.366% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -12.222% |
| Skye Bioscience, Inc. | -13.54 Million USD | 40.679% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -440.303% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -32046.116% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -106.897% |
| IMV Inc. | -35.52 Million USD | 77.377% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 49.359% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -221.209% |
| GB Sciences, Inc. | -1.41 Million USD | -465.999% |
| Alpha Cognition Inc. | -9.7 Million USD | 17.197% |
| HST Global, Inc. | -5303.00 USD | -151446.841% |
| CSL Limited | 4.78 Billion USD | 100.168% |
| Halberd Corporation | -74.27 Thousand USD | -10719.382% |
| Enzolytics Inc. | -2.12 Million USD | -278.719% |
| Resverlogix Corp. | -11.74 Million USD | 31.557% |
| Affymax, Inc. | -14.29 Million USD | 43.781% |
| SYBLEU INC | -141.57 Thousand USD | -5576.677% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -162.373% |
| argenx SE | -216.02 Million USD | 96.28% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 85.478% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 760.356% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -436.16% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 2221.329% |
| AVAX Technologies, Inc. | -6.11 Million USD | -31.474% |
| Zenith Capital Corp. | -8.6 Million USD | 6.617% |
| Genscript Biotech Corporation | -248.71 Million USD | 96.769% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -46031.273% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -228.496% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -4465.578% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 79.725% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -177.857% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -668.082% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 119620.062% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -359.23% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -318.371% |
| BioStem Technologies, Inc. | -7.55 Million USD | -6.393% |
| ONE Bio Corp. | 13.61 Million USD | 159.036% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -4337.914% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -290.692% |
| Agentix Corp. | -1.37 Million USD | -485.857% |
| LadRx Corporation | 412.28 Thousand USD | 2049.275% |
| Cell Source, Inc. | -4.27 Million USD | -88.098% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -2088.472% |
| Regen BioPharma, Inc. | 1.46 Million USD | 648.211% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -757.734% |
| NovAccess Global Inc. | -1.03 Million USD | -676.629% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 190.769% |
| Itoco Inc. | -1.86 Million USD | -329.992% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -2016.993% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -620.119% |
| Kadimastem Ltd | -2.62 Million USD | -206.226% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -3260.455% |
| CytoDyn Inc. | -18.02 Million USD | 55.424% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -10069.089% |
| Mobile Lads Corp. | -2.24 Million USD | -258.588% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -65616.976% |
| Qrons Inc. | -40.08 Thousand USD | -19950.72% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -1554.703% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 1623.706% |
| Rebus Holdings, Inc. | -951 Thousand USD | -745.061% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -656.728% |
| International Stem Cell Corporation | 202 Thousand USD | 4078.48% |
| Bioxytran, Inc. | -3.82 Million USD | -110.372% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -15166.962% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -226.432% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 77.595% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -17758.953% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -193.518% |
| Neutra Corp. | -181.24 Thousand USD | -4334.02% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 60.134% |
| PureTech Health plc | -11.62 Million USD | 30.88% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 60.132% |
| IXICO plc | -707 Thousand USD | -1036.708% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -4.574% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 83.377% |
| CSL Limited | 4.73 Billion USD | 100.17% |
| Cellectis S.A. | -92.63 Million USD | 91.325% |